Opgen Inc
OPGN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$242.67M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $242.67 Million |
|---|---|
| Enterprise Value | $244.28 Million |
| Earnings per Share | $2.33 |
| Beta | -1.93 |
| Outstanding Shares | 12,378,671 |
Return
| Return on Equity | 83.85% |
|---|---|
| Return on Assets | 71.03% |
| Return on Invested Capital | 85.75% |
Valuation & Multiples
| P/E Ratio | 1.82 |
|---|---|
| PEG | 0.16 |
| Price to Sales | 3.99 |
| Price to Book Ratio | 3.99 |
| Enterprise Value to Revenue | 3.21 |
| Enterprise Value to EBIT | 3.76 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
April 2, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Opgen Inc
3 employees
CEO: Oliver Schacht
CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States an...